Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Adrienn, Marton"'
Autor:
Attila Doros, Szilárd Török, László Kóbori, Adam Remport, Adrienn Marton, László Wagner, Marina Varga, Anikó Smudla, Anita Haboub-Sandil, Orsolya Cseprekál, János Fazakas, Attila Patonai, Zsuzsanna Gerlei, Katalin Földes
Publikováno v:
Orvosi Hetilap. 161:1310-1321
Absztrakt: Az új koronavírus okozta COVID–19-járvány kihívást jelent a szervátültetett betegek ellátását illetően is, ezért lényegesnek tartjuk az ezzel kapcsolatos friss ismeretek megosztását a hazai ellátásban dolgozók számár
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4608fe953e35423a964e8713cb53fe33
https://doi.org/10.1556/650.2020.31923
https://doi.org/10.1556/650.2020.31923
Autor:
Szilárd Török, Z Mathe, Orsolya Cseprekál, Sara Molnar, Adam Remport, László Kóbori, Adrienn Marton, Attila Fintha, Tamás Micsik, László Wagner, Attila Patonai
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Pretransplant or de novo donor specific antibodies (DSA) may lead to active or chronic active antibody mediated rejection (a and cABMR) as leading cause of graft loss after kidney transplantation. There is no treatment protocol ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bcee1b9e84ac032deb5b0ae3cfe2830
https://doi.org/10.1093/ndt/gfaa142.p1758
https://doi.org/10.1093/ndt/gfaa142.p1758
Autor:
Szilárd Török, Orsolya Cseprekál, Adrienn Marton, Istvan Mucsi, Adam Remport, László Wagner, Miklos Z. Molnar
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Tacrolimus is an integral part of the immunosuppressive regimen after solid organ transplantation. Due to its narrow therapeutic window, it requires frequent serum trough level (C0) monitoring and dose adjustment. Both over-and un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9050b03eebda2e147363023258113566
https://doi.org/10.1093/ndt/gfaa142.p1666
https://doi.org/10.1093/ndt/gfaa142.p1666
Autor:
Ádám, Remport, Zsuzsanna, Gerlei, Orsolya, Cseprekál, László, Wagner, Katalin, Földes, Adrienn, Marton, Attila, Patonai, Szilárd, Török, Anita, Haboub-Sandil, Marina, Varga, Attila, Doros, Anikó, Smudla, János, Fazakas, László, Kóbori
Publikováno v:
Orvosi hetilap. 161(32)
Due to the COVID-19 pandemic caused by infection with the novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant medicine also had to face a new, hitherto unknown challenge. To be prepared for any possibility, we consider it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10d0523664ee188edaeb13a9e489e4b8
https://pubmed.ncbi.nlm.nih.gov/32750019
https://pubmed.ncbi.nlm.nih.gov/32750019
Autor:
Alexander Lukasz, László Sallai, Philipp Kümpers, Orsolya Cseprekál, Adrienn Marton, Adam G. Tabak, István Kiss, Zsófia K. Németh, Gabriella Godina, Katalin Farkas, Jan T. Kielstein, Zoltán Járai, János Nemcsik, András Tislér, J. Egresits
Publikováno v:
Journal of Hypertension. 35:1109-1118
Objective The role of biochemical and functional markers of microvascular dysfunction to predict cardiovascular outcomes in nondialyzed chronic kidney disease (CKD) remains unclear. In this prospective cohort study, we assessed whether biochemical [s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b9eb8bc1bed45f7820bcce8871ec59b
https://doi.org/10.1097/hjh.0000000000001256
https://doi.org/10.1097/hjh.0000000000001256
Autor:
Zsófia Nemcsik-Bencze, Zoltán Járai, Adrienn Marton, L. Sallai, Adam G. Tabak, L. Kerkovits, Orsolya Cseprekál, Levente Babos, G. Godina, Katalin Farkas, K I Kárpáthi, Zsófia K. Németh, István Kiss, János Nemcsik, András Tislér, J. Egresits, Erzsébet Fodor
Publikováno v:
Journal of Human Hypertension. 30:449-455
Measures of small and large artery dysfunction have not been investigated in a single cohort for the prediction of cardiovascular (CV) events in patients with nondialysed (ND) chronic kidney disease (CKD). This prospective cohort study aimed to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56fad9204da9d475b2068f29b725e3e0
https://doi.org/10.1038/jhh.2015.96
https://doi.org/10.1038/jhh.2015.96
Autor:
Zsuzsanna M. Lenard, Adrienn Marton, Dávid Korda, Zsuzsanna Gerlei, Attila Doros, Orsolya Cseprekál, László Wagner, Szabolcs Takács, Zoltan Mathe, Zsuzsanna Jakab, Anita Haboub-Sandil, Dénes B. Horváthy, Marina Varga
Publikováno v:
European journal of gastroenterologyhepatology. 30(1)
Direct-acting antiviral agents have revolutionized hepatitis C therapy, and are also found to be effective in the liver transplant setting. The extent of liver fibrosis influences patient management and is used to monitor therapeutic effects. Shear-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a4b68483e2212c0f470961e53274b3
https://pubmed.ncbi.nlm.nih.gov/29049126
https://pubmed.ncbi.nlm.nih.gov/29049126
Autor:
Cs. Almasi, Adrienn Marton, M. Zs. Molnar, Peter L. Lakatos, Cs. Ambrus, Klara Berta, Zs. Nemeth, Cs. Horvath, Miklós Szathmári, G Deák, Istvan Mucsi
Publikováno v:
International Urology and Nephrology. 43:191-201
The relationship between parathyroid function, an important determinant of bone turnover, and bone mineral density (BMD) in patients with chronic kidney disease is not fully understood. We wanted to analyze the association between BMD and parathyroid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32b24666065a1b09791f49d8a8471434
https://doi.org/10.1007/s11255-009-9702-2
https://doi.org/10.1007/s11255-009-9702-2
Publikováno v:
International Urology and Nephrology. 42:723-739
Disorders of bone and mineral metabolism affect almost all patients with advanced chronic kidney disease (CKD). High prevalence of decreased bone mineral density has been reported in this population; however, the role and diagnostic utility of bone d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d58f55aa6f4f3ceb9b9e7f08fa5e5d9
https://doi.org/10.1007/s11255-009-9666-2
https://doi.org/10.1007/s11255-009-9666-2
Autor:
Cs. Almasi, Klara Berta, Péter Lakatos, András Szabó, Cs. Horvath, Cs. Ambrus, G Deák, Adrienn Marton, Istvan Mucsi
Publikováno v:
Clinical Nephrology. 64:288-294
Aims: An increasing amount of evidence suggests that 25-hydroxy vitamin D 3 (25(OH)D 3 ) may contribute to the bone health of patients with chronic kidney disease (CKD). The underlying vitamin D status of these patients, however, has often been negle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d204bcd6ee0b8d41fb68c26780b09356
https://doi.org/10.5414/cnp64288
https://doi.org/10.5414/cnp64288